MolecuLight Highlights Clinical Advantages in Reconstructive Surgery at Maui Symposium

Advancements in Wound Care: MolecuLight at JAB Maui Symposium

MolecuLight Inc., a leading innovator in point-of-care fluorescence imaging for wound care, made an important announcement regarding its participation at the 47th Annual JAB Maui Burn & Wound Symposium. Renowned board-certified plastic surgeon and wound care clinician, Dr. Michael N. Desvigne, is set to present significant findings on the clinical and surgical benefits of MolecuLight's unique technology from January 25-30, 2025. This prestigious event will delve into the latest breakthroughs in burn care, infection control, and wound healing, with contributions from leading medical professionals.

Dr. Desvigne's presentation will explore his extensive experience using Fluorescence Imaging for managing infections and preparing wound beds for surgical reconstruction of skin defects. Through his research, he highlights the transformative effects of MolecuLight's fluorescence imaging platform on infection management and wound preparation, demonstrating its ability to enhance surgical outcomes and promote faster recovery for patients with intricate wounds, particularly those undergoing reconstructive procedures involving grafts, flaps, or skin substitutes.

As a Fellow of the American College of Surgeons and a member of the American Society of Plastic Surgeons, Dr. Desvigne leads a multidisciplinary team at Abrazo Arrowhead Hospital and Wound Clinic in Glendale, Arizona. This collaborative effort includes a diverse group of healthcare professionals, ranging from wound care specialists to surgeons, ensuring comprehensive care for complex cases in wound management and surgical reconstruction. The integration of MolecuLight's technology into their practice has contributed to outstanding results in treating wound infections and managing surgical challenges.

In Dr. Desvigne's own words, "The ability to visualize bacterial infection in real-time utilizing MolecuLight's fluorescence imaging has completely revolutionized our clinical processes. This technology allows us to make informed treatment decisions across all surgical cases, leading to improved patient outcomes and quicker recoveries—all while ensuring cost-effective care. I'm eager to share these insights with my peers at the JAB Maui Symposium and help further the field of wound care."

CEO Anil Amlani of MolecuLight expressed excitement over Dr. Desvigne's participation, stating, "We are privileged to have Dr. Desvigne share his vital research and clinical insights at this prominent symposium. His presentations will demonstrate how our fluorescence imaging technology is revolutionizing infection management and enhancing patient outcomes in various surgical and wound care contexts. Enhanced outcomes also contribute to more economical care."

MolecuLight's fluorescence imaging technology stands out in its ability to detect and visualize bacterial infections in real-time, empowering clinicians to make well-informed treatment choices and enabling faster healing processes. Dr. Desvigne's extensive clinical application of MolecuLight's platform emphasizes its pivotal role in improving outcomes for patients with complex wound care and surgical needs.

MolecuLight Inc. is renowned as a privately owned medical imaging enterprise with a global footprint, producing and marketing the MolecuLight iX® and DX™ wound imaging devices. Recognized as the sole class II FDA-cleared point-of-care imaging solutions for real-time evaluation of elevated bacterial load in wounds, these advanced technologies also facilitate precise digital measurements crucial for comprehensive wound management, backed by substantial clinical research comprising over 100 peer-reviewed publications. Interested parties can contact Hunter Zudans, Director of Marketing, for sales or media inquiries related to MolecuLight's groundbreaking technology.

Overall, Dr. Desvigne’s upcoming presentation at the JAB Maui Burn & Wound Symposium underscores the significant evolution in wound care technologies and practices, emphasizing the importance of collaboration and innovation in achieving optimal patient care.